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INTRODUCTION
Mesangial and glomerular cell proliferations are impor-
tant histologic findings in renal disease, but their prognos-
tic implications has been difficult to assume due to the his-
tologic variety. The glomerular mesangium, which was
originally considered to support the glomerular capillaries,
has subsequently been shown to have other important func-
tions in renal diseases, such as phagocytic properties clear-
ing capillary walls (1, 2). More recently, it has been demon-
strated that mesangial cells can synthesize and release growth
factors, interleukins, and other cytokines. With the demon-
stration of contractile proteins in mesangial cells (3, 4),
their resemblance to smooth muscle cells has been empha-
sized. Data from experimental glomerulonephritis (5) indi-
cate that mesangial cell proliferation is accompanied by
increased  -smooth muscle actin (ASMA). Semi-quantita-
tive studies conducted by Alpers et al. (6) and MacPherson
et al. (7) have extended these investigations to human coun-
terparts and found that ASMA is also increased in human
glomerular disease. Hewitson and Beaker (8) identified
interstitial and glomerular myofibroblasts by morphology
and ASMA immunostaining at light and electron micro-
scopic levels.
The monoclonal antibody Ki-67 reacts with human
nuclear cell proliferation associated antigen expressed in all
active parts of the cell cycle. The antibodies MIB1-3 against
recombinant parts of the Ki-67 antigen are Ki-67 equiva-
lents, as demonstrated by immunostaining of formalin-
fixed, paraffin-embedded sections (9). The Ki-67 prolifera-
tion marker is another nuclear non-histone protein (10)
expressed in proliferating cells throughout all phases except
G0 and early G1, with  maximum expressions in G2 and M
phases. Antibodies against Ki-67 have been used to visual-
ize proliferating cells in normal kidneys as well as in renal
biopsy specimens from glomerulopathies (11-13). However
no specific attempt has been made to evaluate the relation-
ship between the disease activity and the rate of cell prolif-
eration. The purpose of this study was to determine the
quantitative ASMA and the cell proliferation marker Ki-67
in glomerular diseases with an effort to correlate them.
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Immunohistochemical Study of the Expression of  -Smooth Muscle
Actin and the Proliferation Marker Ki-67 of Glomerulonephritis
The aim of this study was to determine the relationship of  -smooth muscle
actin (ASMA) and the proliferation marker Ki-67 of glomerulonephritis (GN).
Immunohistochemical stainings with the usual streptavidin-biotin peroxidase
method were performed on 86 renal biopsies using monoclonal 1A4 and Ki-67.
The results of the quantitative evaluation of ASMA and Ki-67 were analyzed for
the correlation between positive value of ASMA and Ki-67 in different GN.
ASMA expressions of glomeruli were highest in acute post-infectious GN
[APGN; 16.9 Fraction Volume (FV)%], followed by unclassified proliferative GN
(UnGN; 12.5 FV%), membranoproliferative GN (MPGN; 8.5 FV%), lupus nephri-
tis (LupusN; 6.3 FV%), IgA nephritis (IgAN; 5.6 FV%), and normal control (0.1
FV%). The Ki-67 staining was considerably elevated in lupusN (4.3 Ki-67 posi-
tives/glomerulus), APGN (2.7), MPGN (2.5), UnGN (1.66), IgAN (0.5), compared
with that in normal control group (0.1 Ki-67 positives/glomerulus). Ki-67 value in
each category of glomerular diseases was significantly different from that in the
control biopsies (p<0.004). The relationship between morphometric results of
ASMA and Ki-67 was statistically significant regardless of the diagnosis.
(rs=0.425, p=0.000, ASMA= 0.1113+0.1665 Ki-67). In conclusion, the immuno-
histochemical assessment of ASMA and Ki-67 expression in GN might be a reli-
able indicator for the progression of GN. This study indicates that active cellular
proliferation is associated with increased actin deposition in glomeruli.
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MATERIALS AND METHODS
Tissue sample
This study used renal biopsy specimens obtained from 86
patients over the last 10 yr from the Department of Pathol-
ogy, Ewha Womans University Hospital, Seoul, Korea. The
series included 12 cases of acute post-infectious glomeru-
lonephritis (APGN), 5 cases of membranoproliferative
glomerulonephritis (MPGN), 10 cases of lupus nephritis
(LupusN), 50 cases of IgA nephropathy (IgAN), and 9 cases
of unclassified proliferative glomerulonephritis (UnGN).
These cases were diagnosed according to light microscopi-
cal, electron microscopical, and immunofluorescence micro-
scopical criteria of the World Health Organization (WHO).
Ten renal specimens from surgically removed kidney speci-
mens due to focal neoplasm, which were confirmed as nor-
mal renal parenchyme by routine diagnostic procedure,
used as the control group.
Routine stainings 
Biopsy specimens were fixed in 4% neutral buffered
formaldehyde, embedded in paraffin, sectioned 4  m thick,
and stained with hematoxylin-eosin (H&E), periodic acid-
Schiff (PAS), silver methenamine (GMS), and Masson-
trichrome (MT).
Immunohistochemistry
Immunohistochemical staining for ASMA using the
avidin-biotinylated horseradish peroxide complex system
was performed by mouse monoclonal antibodies [ASMA
Ab-1 (clone 1A4), NeoMarkers, Fremont, CA, U.S.A.].
Formalin fixed paraffin-embedded tissue sections were de-
paraffinized and endogenous peroxidase activity was blocked
with 2% hydrogen peroxide in methanol for 40 min at
room temperature. Sections were incubated with 5% fetal
calf serum for 20 min at room temperature to block non-
specific binding, and then with primary antibodies at a
dilution of 1:100 ASMA overnight at 4℃. On the next
day, secondary biotinylated mouse antibodies were applied
to mouse immunoglobulin (NeoMarkers) at a dilution of
1:100 in fetal calf serum for 30 min at room temperature.
Sections were incubated with streptavidin-biotin complex/
horseradish peroxide (NeoMarkers) at a dilution of 1:100
for 30 min at room temperature. After washing in phos-
phate-buffered saline (PBS) buffer with 0.05 M Tris buffer,
the sections were stained using fresh 3.3 diaminobenzidine
tetrahydrochloride as a chromogen with 0.03% hydrogen
peroxide for 7 min for immunohistochemical demonstra-
tion of actin. Finally, the sections were counter-stained with
Mayers hematoxylin and mounted in Kaisers glycerol gelatin.
Immunohistochemical staining for Ki-67 using rabbit
antihuman Ki-67 antigen (DAKO Code No. N1574 Via
Real, CA, U.S.A.) was performed. Four  m thick sections
were mounted on silanized slides (DAKO Code No. S3003),
air-dried, and de-paraffinized through xylene and graded
alcohol series. Endogenous peroxidase was inhibited with
0.3% hydrogen peroxide. After washing specimens in PBS,
antigen retrieval was petformed using wet autoclave pre-
treatment in 0.01 M/L citrate buffer for 15 min at room
temperature and incubated with MIB-1 diluted at 1:50
overnight at 4℃. After rinsing three times in PBS, sections
were further incubated for 30 min with bio-tinylated sheep
anti-mouse immunoglobulins and streptavidin-biotin-per-
oxidase complex at room temperature. 3,3-diaminobenzi-
dine was used as a chromogen. Crypt epithelial cells from
colonic mucosal biopsy specimens were used as positive
controls.
Morphometrics
A quantitative estimate for each of the biopsy specimen
was carried out. Fraction volume for ASMA at glomerulus
was quantitated by point counting using an eyepiece gratic-
ule of 1 cm2 with ten equidistant lines at a magnification of
×400, OCM eyepiece Micrometer (OCM 10/10 SQ, Olym-
pus, Japan). Numbers of positive area on micrometer were
counted and divided by numbers of total glomerular cros-
sied section on micrometer, then multiplied by 100 to cal-
culate fraction volume per cent. The results were expressed
as fraction volume (FV) (8) according to the formula.
The mean FV in various glomerular diseases was com-
pared by Student t-test. Following immunohistochemical
staining for Ki-67 antigen, glomeruli from each biopsy
were examined and the number of Ki-67-positive cells per
glomerular cross section (Ki-67 positives/glomerulus) was
counted. The total number of glomerular cells per glomeru-
lar cross section (TGC) was determined by counting the
number of cells as one fraction of glomeruli and multiply-
ing the total number of fractions. The cell proliferation
index (PI) was calculated as the number of Ki-67-positive
nuclei per 1,000 glomerular nuclei. A Student t-test was
used to compare means and variations from diseased and
control specimens. Pearson’ s correlation coefficient for ASMA
and Ki-67 values was also determined.
RESULTS
The staining intensities and location within glomeruli of
number of grid intersections 
with positive staining
total number of grid 
intersections
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ASMA were essentially uniform and showed similar pat-
terns, albeit some different staining areas depending on the
different glomerular diseases and the disease activity.
All sections from the control and study groups showed
intense staining by ASMA in the tunica media of the renal
blood vessels and the interstitial tissue surrounding the
blood vessels, which served as internal controls (Fig. 2A).
Our quantitative data expressed by points are summarized in
Table 1. Within the control group, there were approximately
80 examined glomeruli in all biopsies, whereas in the groups
with glomerulonephritis the number of examined glomeruli
ranged from 45 to 570, according to the disease.
The mesangial actin-positive area by point counting was
small in the normal control group (range, 0-0.25 FV% of
total glomerular area). The greatest actin-positive areas
appeared in 12 cases of APGN (Table 1) with a mean value
of 16.9 FV% (range, 2.5-27.1) (Fig. 2B, C), followed by nine
cases of UnGN with a mean value of 12.57 FV% (range, 0-
39.6), 5 cases of MPGN with 8.58 FV% (range, 1.1-21.9),
10 cases of LupusN with 6.33 FV% (range, 0-13.9), and 50
cases of IgAN with 5.67 FV% (range, 0-33.7) (Fig. 2D).
The disease with the least actin-positive areas was IgAN.
The ASMA values of all glomerular diseases were signifi-
cantly different from those in the control group biopsies
(p<0.011), confirmed by one-way ANOVA with multiple
comparison tests (p=0.001). The most active proliferative
disease showed an increased amount of actin deposition,
while the least actin deposition was seen in IgAN. It is thus
possible that the greater damage and stimulation resulted
in the larger areas of actin deposition. APGN and UnGN
had a greater tendency for mesangial fibrosis and crescent
formation as well as periglomerular fibrosis, while most of
IgAN showed minimal mesangeal change by routine his-
tology.
Nuclei stained positive for the Ki-67 antigen were pre-
sent in all the biopsies, including the control group, where
they were few.  In the groups with glomerulonephritis, Ki-
67 (MIB-1)-positive nuclei were seen in all types of cells,
including visceral epithelium and mesangial cells. The mean
values of total glomerular cells (TGC), Ki-67-positive cells
per glomerular cross section (Ki-67 pos/glo), and prolifera-
tion index (PI, Ki-67 pos. cell/1000 glomerular cells) in all
the control and disesased groups are summarized in Table 2.
Ki-67 positivity and PI were highest in LupusN followed
by APGN (Table 2) (Fig. 3B). Ki-67 positivity were 4.31 in
LupusN (Fig. 3A), 2.76 in APGN, 2.5 in MPGN, 1.66 in
APGN IgAN Normal MPGN LupusN UnGN
No. of cases 10 50 12 5 10 9
No. of glomeruli 80 570 110 45 96 95
Morphometric criteria
Actin (FV %) 0.11±0.11 5.67±6.96 16.94±8.03 8.58±9.34 6.33±4.78 12.57±13.76
Range 0-0.25 0-33.79 2.5-27.1 1.1-21.9 0-13.9 0-39.6
p value (versus control) - 0.011 < 0.001 0.001 0.001 0.011
Table 1. Glomerular expression of ASMA in 86 specimens with glomerular diseases
Data of Actin are expressed as mean with standard deviation. FV %, Fraction volume percent; IgAN, IgA nephropathy; APGN, acute post-infectious
glomerulonephritis; MPGN, membranoproliferative glomerulonephritis; LupusN, lupus nephritis; UnGN, unclassified proliferative glomerulonephritis
APGN IgAN Normal MPGN LupusN UnGN
No. of cases 10 50 12 5 10 9
No. of glomeruli 80 570 110 45 96 85
Total glomerular cells 76.90±4.58 137.52±28.64 181.08±42.89 140.58±52.36 179.62±61.79 162.71±41.19
p value (versus control) - < 0.001 < 0.001 0.002 0.001 0.001
Ki-67 pos/glo 0.11±0.17 0.56±0.98 2.76±1.29 2.50±0.70 4.31±2.63 1.66±1.44
p value (versus control) - 0.003 < 0.001 < 0.001 < 0.001 0.004
Proliferation index 1.35±2.04 4.30±7.09 14.41±6.88 13.60±0.42 19.62±8.75 9.16±7.38
p value (versus control) - 0.018 < 0.001 < 0.001 < 0.001 0.007
Table 2. Total glomerular cells, Ki-67 proliferation marker, and proliferation index in 86 specimens with glomerular diseases
Data are expressed as mean with standard deviation. Ki-67 pos/glo, Ki-67 positive cells per glomerular cross section
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Fig. 1. Correlation of ASMA with Ki-67 positive cells/glomerular
section in glomerulitis. 
y=2.5542x + 2.605
R2=0.4252458 O. Kim
UnGN, and 0.56 in IgAN. All values of Ki-67 were signif-
icantly different from the value of the control group (p<
0.004), and Ki-67 values in individual groups were also sig-
nificantly different from each other by one-way ANOVA
(p<0.01). The PI were 19.62 for LupusN, 14.41 for APGN,
13.6 for MPGN, 9.16 for UnGN, and 4.30 for IgAN. Each
of the PI values in disease groups were significantly differ-
ent from that of the control group (p<0.018). 
As for the correlation between ASMA and Ki-67, a statisti-
cal significance was noted. Regardless of the diagnosis, the
C D
A B
Fig. 2. Expression of ASMA in normal and diseased glomeruli: (A) ASMA in control cases: negative in glomerular tuft and positive in mus-
cular coat of arterioles (×200). (B) ASMA in mesangial proliferative APGN: diffuse positive in mesangium (×200). (C) ASMA in crescent
of APGN: mainly positive in mesangium (×400). (D) ASMA in IgA Nephropathy; segmental mesangial positive expression (×200).
A B
Fig. 3. Expression of Ki-67 proliferation marker in diseased glomeruli. (A) Ki-67 positive cells in endocapillary and mesangium in a case
with LupusN (×400). (B) Ki-67 positive cells in endocapillary and crescentic epithelium in a case of APGN (×400). -Smooth Muscle Actin and Proliferation Marker Ki-67 of Glomerulonephritis 459
correlation coefficient (Pearson correlation) and regression
coefficient were significant between ASMA and Ki-67 (rs=
0.425, p=0.000, ASMA=0.1113+0.1665 Ki-67; Fig. 1).
Therefore, the increase of actin deposition was accompanied
by an increase of glomerular cellularity in most cases. There
was a positively linear relationship between glomerular
ASMA expression and glomerular cell proliferation. Accor-
dingly, the greatest cell proliferation was concentrated in
those glomerulopathies with the highest expression of
ASMA, as in APGN and proliferative lupusN.
DISCUSSION
Actin is found in eukaryotic cells and constitutes one of
the most abundant cellular proteins available. At least six
isoforms exist, among which ASMA is a good marker for
smooth muscle differentiation and is considered almost spe-
cific for smooth muscle tissue (14, 15). Because of the well
documented resemblance of mesangial cells to smooth mus-
cle cells and their contractile properties (3, 4), ASMA might
be expressed in mesangial cells. It is therefore surprising that
ASMA is not expressed at all in the glomerulus of the nor-
mal rats (5, 16, 17) and that mesangial cells are only faintly
stained for ASMA in normal human glomeruli (6, 7). How-
ever, it has been reported that ASMA is expressed in mesan-
gial cell cultures and in several conditions with mesangial
cell activation in experimental models (5, 17-20).
Using subjective semi-quantitative scoring, Alpers et al.
and MacPherson et al. found a increased ASMA in mesan-
gial cells in many human glomerular diseases. Among the
various categories of glomerular diseases, MPGN and IgAN
showed increased staining in series on semi-quantitative
evaluation, but the number of cases in each group was too
small (7). The total series of biopsies with glomerular dis-
eases showed an increased expression of ASMA in the
mesangial region, which was statistically significant (p<
0.015), but except for lupusN, the number of cases in each
disease category was too small to allow statistical evalua-
tion: in the series all of the eight cases of IgAN, three cases
of APGN, and three cases of MPGN showed increased
scores for ASMA expression (6). Also it was confirmed that
increased interstitial myofibroblasts in IgAN by morpholo-
gy and ASMA immunostaining (8).
In the present investigation, the greatest actin deposition
was found in patients with APGN (16.9 FV%), followed
by UnGN, MPGN, LupusN, and IgAN. The disease with
the least expression of actin was IgAN (5.67 FV%). In our
cases of APGN, mostly from adult patients with an average
age of 22 yr. Among 12 cases of APGN, the histology shows
crescent formation in 6 cases, diffuse hypercellularity in 4,
and mesangial fibrosis as well as periglomerular and inter-
stitial fibrosis in 2.
All ASMA values for glomerular diseases were signifi-
cantly different from that in the control biopsies (p<0.011).
It was reported that IgAN showed a variation of ASMA
expression (range 0.1-27.7 FV%), which was also observed
in our study (9). It is likely that the staining of actin is due
to its expression in mesangial cells. Other cells, however,
such as macrophages, might have emigrated into the me-
sangium and expressed actin. The interstitial cells express-
ing ASMA could be interpreted as interstitial myofibrob-
lasts, pericytes or perivascular adventitial cells (21). Increa-
sed ASMA immunoreactivity revealed in fibrotic areas
could be due to the presence of these cells. However inflam-
matory reaction as well as interstitial fibrosis are minimal
and seen in only a few cases.
There are many categories of glomerular diseases with
hypercellular mesangium. Quantitative methods (5) have
improved the quality of data formerly obtained exclusively
by subjective evaluation. In APGN, both endocapillary and
mesangial hypercellularity have been reported (23). Mesan-
gial hyperplasia has also been reported in focal proliferative
glomerolonephritis, most likely in the cases of IgAN.  How-
ever it was also reported that the mesangial cell prolifera-
tion in normal glomeruli was found (24, 25).
In all of our biopsy specimens, total glomerular cells, PI,
and proliferation markers Ki-67 were analyzed. The greatest
Total glomerular cell value was observed in APGN (181/
glomerulus) followed by LupusN (179), while the least value
was in IgAN (137). The greatest value of PI was LupusN
(19.6), followed by APGN (14, 4), while the least value of
PI was in IgAN (4.3). The greatest value of Ki-67 was noted
in LupusN (4.3/glomerulus), followed by APGN (2.76),
while the least was in IgAN (0.56). There was no statisti-
cally significant correlation between groups of Ki-67, TGC,
and PI by Pearson correlation in our series, while it was
reported that Ki-67 and PI were significantly correlated (9).
The Ki-67 antigen is expressed in the cell nucleus in all
stages of the cell cycle except G0 (26, 27). The anti-Ki-67
antibody works on cryostat section only, but a monoclonal
antibody to the antigen MIB-1, which is generated using
recombinant parts of the antigen, immunostains formalin-
fixed paraffin-embedded tissue following microwave anti-
gen retrieval (28). The Ki-67 antigen expression measured
by this technique correlates well with the mitotic figure
index (29) and is considered a reliable tool to measure cell
proliferation.
As we have expected, the highest Ki-67 expression was
observed in cases of LupusN, followed by APGN, MPGN,
UnGN, and IgAN. The present data show that the diffuse
involvement of mesangium in the activation and injury
processes can take place even in apparently normal appearing
glomeruli. IgAN is of great practical value and may predict
the progression of the disease. It could also be assumed that
the outcome of the earliest lesion visible at the light micro-
scopical level. It has been reported that the assessment of
proliferation activity in IgAN by immunohistology provid-460 O. Kim
ed an additional information on the disease activity and
prognosis (30). The importance of mesangial activation and
proliferation for the progression of glomerulopathies is cur-
rently under investigation (16, 17, 20). It is highly proba-
ble that the mesangial cells are involved in the disease pro-
cess by regulating glomerular hemodynamics and synthesis
of mesangial matrix, and as a consequence, by the develop-
ment of glomerular sclerosis (31). In glomerulonephritis,
Ki-67-positive cells might be either mesangial cells or mono-
cytes/macrophages infiltrating capillary loops. Some in-
flammatory cells infiltrating the renal interstitium were
also positively stained with the MIB-1 antibody.
Studies on the correlation between morphometrically
determined glomerular ASMA expression and the prolifera-
tion marker Ki-67, on one hand, and functional data of
long-term follow up, on the other, should be performed in
order to assess whether these parameters are useful in deter-
mining the disease activity and prognosis. The present data
may provide an important basis for such studies. Regardless
of the diagnosis, however, the correlation coefficient and
regression coefficient were statistically significant between
ASMA and Ki-67.
There was positive and linear relationship showing that
the highest cell proliferation was concentrated in those
glomerulopathies with the highest expression of ASMA,
such as APGN and LupusN. An increase of cellular prolif-
eration rate represents a kind of cardinal pathological event
in a variety of kidney diseases. To evaluate proliferative
activity, immunohistological labeling of PCNA and Ki-67
nuclear markers were used in both snap-frozen (10) and for-
malin-fixed paraffin-embedded renal biopsy specimens (12,
13, 32, 33). The morphometric estimates demonstrated
that different ASMA expression in types of GN affected the
prognosis. The finding of other reports, along with the lack
of correlation between ASMA expression and proliferation
markers indicates that the role of ASMA in GN is complex
(9). In another recent study, it was mentioned a rough cor-
relation between the interstitial count of proliferating cells
and the proportion of biopsy specimens from patients with
increased serum creatinine concentration (13).
In a relatively large homogeneous series, it was documen-
ted a correlation of the proliferation rate in the kidney as
assessed by the Ki-67 antigen expression with a variety of
clinical and histological indicators of disease activity and
with prognosis of the disease. The data suggest that quanti-
tative immuno-visualization of proliferating renal cells, pri-
marily in the interstitial compartment, may provide clini-
cally relevant information complementary to that obtained
by conventional pathological techniques (30). Radford et al.
(1997) postulated that characterization of proliferative
activity using antibodies against the Ki-67 antigen might
be useful as an additional marker for predicting the likeli-
hood of progressive renal failure in IgAN (33).
As seen in Table 1, the enhanced expression may be seen
in any form of glomerular injury, and marked increases are
common in proliferative GN, such as APGN and diffuse
proliferative LupusN. This finding is in close line with
those findings in studies of immune complex-mediated
mesangial injuries in rats, where marked expression of
ASMA by mesangial cells was revealed to correlate with the
onset of cellular proliferation (22).
It was determined that there is a strong association be-
tween ASMA expression and cellular proliferation in the
glomerulus. Therefore, our observations indicate that enhan-
ced ASMA expression in human glomeruli may be best
interpreted as an indication of mesangial cell proliferation
and activation.
In summary, this study demonstrates that the enhanced
expression of ASMA is a sensitive but non-specific marker of
mesangial injury detectable in fixed tissue sections of human
renal biopsies. In many cases, this enhanced expression is also
a marker for cellular proliferation within glomeruli. Identifi-
cation of the expression of ASMA and Ki-67 in renal biopsies
may eventually prove to have prognostic significance in the
assessment of human glomerular diseases. Therefore this
study indicates that active cellular proliferation associated
with increased actin deposition in glomeruli leads to the
progression of the renal disease.
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